$CYTK
Cytokinetics Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is CYTK up today? It is at $79.30 (+0.57%), and our scanner flagged it 24 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CYTK spikes, and full due diligence on CYTK — key stats, earnings, dilution and insider activity. Free.
Get free $CYTK alerts the moment volume spikes
Our scanner flagged $CYTK 24 times in the last 30 days. Create a free account to track $CYTK, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $79.30
- Change today
- +0.57%
- Previous close
- $78.85
- 52-week range
- $32.89 – $88.31
- Market cap
- $9.81B
- Institutional own.
- 99.9%
- Total held
- 100.0%
- Short interest
- 17.1M ▼ -3% vs prior · as of 2026-07-15
- Days to cover
- 9.0d
- Avg daily volume
- 2.2M
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5m
- 0.6x
- 15m
- 0.5x
- 1h
- 0.5x
- 1D
- 0.0x
Get free CYTK + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $CYTK up today?
Here is the latest on CYTK from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CYTK today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystShareholder Vote, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
15 buys, 19 sells last 3 months (42/88 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Callos Andrew Officer | Sold (automatic/other) | -14K 0.01% of company | sold 19% | 59K | $1.1M at $79.88 | Jul 30, 26 |
Callos Andrew Officer | Other | 14K 0.01% of company | added 24% | 73K | $326K at $23.26 | Jul 30, 26 |
Blum Robert I Officer | Sold (automatic/other) | -8K | sold 1.9% | 378K | $607K at $80.87 | Jul 27, 26 |
Blum Robert I Officer | Other | 8K | added 2.0% | 385K | $80K at $10.60 | Jul 27, 26 |
Malik Fady Ibraham Officer | Sold (automatic/other) | -4K | sold 2.2% | 154K | $282K at $80.59 | Jul 21, 26 |
Malik Fady Ibraham Officer | Other | 4K | added 2.3% | 157K | $27K at $7.80 | Jul 21, 26 |
Daly James M Director | Acquired (grant/award) | +151 | added 4.7% | 3K | $12K at $82.62 | Jul 15, 26 |
Harrington Robert Arthur Director | Acquired (grant/award) | +151 | added 0.7% | 22K | $12K at $82.62 | Jul 15, 26 |
Henderson John T Director | Acquired (grant/award) | +272 | added 0.3% | 78K | $22K at $82.62 | Jul 15, 26 |
Kaye Edward M. Md Director | Acquired (grant/award) | +151 | added 1.5% | 10K | $12K at $82.62 | Jul 15, 26 |
Wierenga Wendell Director | Acquired (grant/award) | +75 | added 0.2% | 36K | $6K at $82.62 | Jul 15, 26 |
Wysenski Nancy Director | Acquired (grant/award) | +75 | added 0.2% | 34K | $6K at $82.62 | Jul 15, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $CYTK runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- Priced at $71.00/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$CYTK Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$CYTK Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to CYTK
Comparable names in pharmaceutical preparations, closest in size first.
CYTK stock FAQ
Why is $CYTK up today?
Here is the latest on CYTK from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CYTK today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the CYTK stock price today?
CYTK last traded at $79.30, up 0.57% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live CYTK alerts?
The CYTK Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CYTK 24 times in the last 30 days.
What exchange is CYTK on?
CYTK (Cytokinetics Inc.) trades on XNAS, with a market cap of about $9.81B in the PHARMACEUTICAL PREPARATIONS sector.
Is CYTK good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CYTK for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.